TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- TScan Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 105.7M, a 18.81% decrease year-over-year.
- TScan Therapeutics Inc. total liabilities for 2025 were 105.7M, a 18.81% decrease from 2024.
- TScan Therapeutics Inc. total liabilities for 2024 were 130.1M, a 7.31% increase from 2023.
- TScan Therapeutics Inc. total liabilities for 2023 were 121.3M, a 21.70% increase from 2022.
- TScan Therapeutics Inc. total liabilities for 2022 were 99.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| TScan Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $106 |
| 2024 | $130 |
| 2023 | $121 |
| 2022 | $100 |
| 2021 | $27 |
| 2020 | $33 |
| TScan Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $106 |
| 2024-12-31 | $130 |
| 2023-12-31 | $121 |
| 2022-12-31 | $100 |
| 2021-12-31 | $27 |
| 2020-12-31 | $33 |
TScan Therapeutics Inc. Total Liabilities — FAQ
TScan Therapeutics Inc. (TCRX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's total liabilities history?
The chart and table above show TScan Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.